Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127471471 | 12747147 | 1 | I | 20160906 | 20160915 | 20160915 | EXP | PHHY2016IT124334 | SANDOZ | 26.00 | YR | M | Y | 0.00000 | 20160915 | CN | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127471471 | 12747147 | 1 | PS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | U | 78528 | ||||||||||
127471471 | 12747147 | 2 | SS | OLANZAPINA TEVA | OLANZAPINE | 1 | Unknown | N | 0 | FILM-COATED TABLET | |||||||||
127471471 | 12747147 | 3 | SS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | U | 0 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127471471 | 12747147 | 1 | Psychotic disorder |
127471471 | 12747147 | 2 | Psychotic disorder |
127471471 | 12747147 | 3 | Psychotic disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127471471 | 12747147 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127471471 | 12747147 | Anxiety | |
127471471 | 12747147 | Disturbance in attention | |
127471471 | 12747147 | Learning disorder | |
127471471 | 12747147 | Listless | |
127471471 | 12747147 | Memory impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |